Humana Inc. Files Form 8-K

TL;DR

Humana filed an 8-K on Dec 1, 2025, updating corporate info. Standard stuff.

AI Summary

Humana Inc. filed a Form 8-K on December 1, 2025, reporting information under Regulation FD. The filing details the company's principal executive offices located at 500 West Main Street, Louisville, Kentucky, 40202, and its telephone number as (502) 580-1000. This report serves as a current update for the company.

Why It Matters

This filing indicates Humana Inc. is providing an update on its corporate information, which is standard procedure for publicly traded companies to maintain transparency with investors.

Risk Assessment

Risk Level: low — This filing is a routine corporate update and does not contain information that suggests a significant change in risk for the company.

Key Players & Entities

• HUMANA INC (company) — Registrant
• 500 West Main Street, Louisville, Kentucky, 40202 (location) — Principal executive offices
• December 1, 2025 (date) — Date of report

FAQ

Key Financial Figures

• $12.26 — reaffirm its guidance of approximately $12.26 in diluted earnings per common share ("
• $17.00 — r common share ("EPS") or approximately $17.00 in adjusted earnings per common share (

Filing Documents

• hum-20251201.htm (8-K) — 34KB
• 0000049071-25-000059.txt ( ) — 148KB
• hum-20251201.xsd (EX-101.SCH) — 2KB
• hum-20251201_lab.xml (EX-101.LAB) — 21KB
• hum-20251201_pre.xml (EX-101.PRE) — 12KB
• hum-20251201_htm.xml (XML) — 3KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. Members of Humana Inc.'s (the "Company") senior management team are scheduled to meet with investors and analysts at various meetings between December 1, 2025 and December 31, 2025. During these meetings, the Company intends to reaffirm its guidance of approximately $12.26 in diluted earnings per common share ("EPS") or approximately $17.00 in adjusted earnings per common share ("Adjusted EPS"), in each case for the year ending December 31, 2025 ("FY 2025"). This guidance is consistent with the guidance issued in the Company's press release dated November 5, 2025. The Company has included Adjusted EPS in this current report, a financial measure that is not in accordance with Generally Accepted Accounting Principles ("GAAP"). Management believes that this measure, when presented in conjunction with the comparable measure of GAAP EPS, provides a comprehensive perspective to more accurately compare and analyze the Company's core operating performance over time. Consequently, management uses Adjusted EPS as a consistent and uniform indicator of the Company's core business operations from period to period, as well as for planning and decision-making purposes and in determination of incentive compensation. Adjusted EPS should be considered in addition to, but not as a substitute for, or superior to, GAAP EPS. A reconciliation of GAAP EPS to Adjusted EPS follows: Diluted earnings per common share FY 2025 Guidance GAAP approximately $12.26 Amortization of identifiable intangibles 0.42 Put/call valuation adjustments associated with the Company's non-consolidating minority interest investments (a) 3.81 Value creation initiatives (a) 2.65 Impact of exit of employer group commercial products business (a) (0.52) Settlement of certain litigation expenses (a) 0.13 Loss on sale of business (a) 0.52 Impairment charges (a) 0.27 Cumulative net tax impact (2.54) Adjusted (non-GAAP) – FY 2025 projected (a) approximately $17.00 (a)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. HUMANA INC. BY: /s/ John-Paul W. Felter John-Paul W. Felter Senior Vice President, Chief Accounting Officer & Controller (Principal Accounting Officer) Dated: December 1, 2025

View Full Filing

View this 8-K filing on SEC EDGAR